Güneydoğu Anadolu bölgesinde meme kanserinde tanı ve tedavide gecikme sebeplerine yönelik anket çalışması
Amaç: Meme kanserinde, bölgemizde hasta ve sağlık sistemi ilişkili gecikmede etkili olan faktörleri incelemektir.Yöntemler: 2012 Aralık-2014 Temmuz tarihleri arasında Dicle Üniversitesi Tıp Fakültesi Hastanesi Genel Cerrahi Kliniğine başvuran son 6 ay içerisinde Meme Kanseri tanısı almış 100 meme kanserli hastaya, hasta onamı alındıktan sonra anket uygulandı. Anket 4 bölüm (hasta ve sistem ilişkili faktörler, demografik veriler ve kanser evresinin değerlendirilmesi) ve 25 sorudan oluşmaktaydı. Bulgular: Meme semptomlarını fark ettikten sonra, üç ay gecikme ile gelenlerin oranı ise %58 idi. Düzenli kontrol edilenlerin oranı %8 idi. Memedeki lezyonunun kanser olabileceğini düşünenlerin oranı %9 iken, bunun ciddi bir durum olmadığını ve kendiliğinden iyileşeceğini düşünenlerin oranı %86 idi. Doktora gitmeme nedenine yönelik soruya, hastaların % 2'si bayan doktor olmadığı için, %7'si bilgisizlikten, %23'ü korktuğundan şeklinde cevap verdi. Hastaların %77' si bir hafta içinde doktor randevusu alabilmiş, %82'si bir hafta içinde mamografi çekimi yapabilmiş, %78'i bir hafta içinde meme biyopsi işlemini yapabilmişti. Kanser korkusu 30-50 yaş aralığındaki kadınlarda istatistiksel anlamlı yüksekti (p
A survey on the factors causing delayed diagnosis and treatment of breast cancer in southeastern Anatolia
Objective: This survey aims to elucidate patient and health system related factors leading to delayed diagnosis and treatment of breast cancer in Southeastern Anatolia.Methods: Hundred patients admitted to Department of General Surgery at Dicle University between December 2012 and July 2014, and diagnosed with breast cancer in preceding 6 months were included in the survey after their consent. The survey has 4 chapters (patient and health system related factors, demographic data, and assessment of cancer stage) and 25 questions.Results: Fifty-eight percent of patients visited a physician with a 3 months delay after realization of breast cancer symptoms. Only 8% of patients had regular check-ups. Nine percent of patients were suspicious of breast cancer due to the lesion in the breast. 86% of patients did not consider it to be a serious matter. Lack of female physicians cited by 2% as the reason for avoiding doctor's visit. Seven percent cited lack of knowledge and 23% being scared. Seventy-seven percent were able to get a doctor's appointment, 82% to get mammography, 78% underwent biopsy in a week. Women between the ages of 30-50 had higher concern about cancer (p
___
- Surveillance, Epidemiology, and Results (SEER). Program (www.seer.cancer.gov): SEER Stat Database: Incidence- SEER 9 Regs Public Use, Nov 2005 Sub (1973-2003). National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission.
- Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collabora- tors: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792.
- Shetty MK, Longatto-Filho A. Early detection of breast, cer- vical, ovarian and endometrial cancers in low resource contries: an integrated approach. Indian J Surg Oncol 2011;2:165-171.
- Dundar PE, Ozmen D, Ozturk B, et al. The knowledge and attitudes of breast self-examination and mammography in a group of women in rural area in western Turkey. BMC Cancer 2006;6:43.
- Saip P, Keskin S, Ozkan M,et al. The access rate to di- agnosis and treatment modalities in breast cancer pa- tients in Turkey; multicenter observational study. J BUON 2011;16:664-671.
- Ozmen V, Ozaydin N, Cabioglu N, et al. Survey on a mam- mographic screening program in Istanbul Turkey. Breast J 2011;17:260-267.
- Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mor- tality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol 2013:20;2468- 2476.
- Rutqvist LE. Waiting times for cancer patients--a "slippery slope" in oncology. Acta Oncol 2006;45:121-123.
- Richards MA. The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Can- cer 2009:3;101 Suppl 2:S1-4.
- Partridge AH, Hughes ME, Ottesen RA, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 2012;17:775-782.
- Sikora K. Genes, dreams, and cancer. MJ 1994:7;1217- 1221.
- Ozmen V, Boylu S, Ok E, et al. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015;25:9-14.
- Fedewa SA, Edge SB, Stewart AK, et al. Race and eth- nicity are associated with delays in breast cancer treat- ment (2003-2006). J Health Care Poor Underserved 2011;22:128-141.
- Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011;11:284.
- Otieno ES, Micheni JN, Kimende SK, Mutai KK. Provider delay in the diagnosis and initiation of definitive treatment for breast cancer patients. East Afr Med J 2010;87:143- 146.
- Norsa'adah B, Rampal KG, Rahmah MA, et al. Diagnosis delay of breast cancer and its associated factors in Malay- sian women. BMC Cancer 2011;11:141-146.
- Chintamani, Tuteja A, Khandelwal R, et al. Patient and provider delays in breast cancer patients attending a ter- tiary care centre: a prospective study. JRSM Short Rep 2011;2:76-82.
- Jassem J, Bacanu F, Eglitis J, et al. Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AVM): An international survey. J Clin Oncol 2012; 30, (suppl; abstr 9046).
- Allgar VL, Neal RD. Delays in the diagnosis of six can- cers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005;92:1959-1970.
- Jassem J, Ozmen V, Bacanu F, et al. Factors influencing time to seeking medical advice and start of treatment in breast cancer - an international survey. Thirty-fifth Annual CTRC-AACR San Antonio Breast Cancer Symposium - December 4-8, 2012; San Antonio, TX (abstract).
- Montella M, Crispo A, D'Aiuto G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001;10:53-59.
- Rauscher GH, Ferrans CE, Kaiser K, et al. Misconcep- tions about breast lumps and delayed medical presenta- tion in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev 2010;19:640-647.
- Robertson R, Campbell NC, Smith S, et al. Factors influ- encing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 2004;90:1479-1485.
- Yau TK, Choi CW, Ng E, et al. Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre. Hong Kong Med J 2010;16:373- 377.
- Hofvind S, Lee CI, Elmore JG. Stage-specific breast can- cer incidence rates among participants and non-partici- pants of a population-based mammographic screening program. Breast Cancer Res Treat 2012;135:291-299.
- Kayhan A, Gurdal SO, Ozaydin N, et al. First round results of a long term population-based breast cancer screening program from Bahçesehir. J Breast Health 2012; 8:180- 184.
- Fornier MN, Modi S, Panageas KS, Norton L. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after ad- juvant anthracycline and taxane. Cancer 2005;104:1575- 1579.
- Online: Türkiye İstatistik Kurumu (Turkish Statistical In- stitute). Available at http://www.tuik.gov.tr [accessed: July 2013].
- Jensen LF, Pedersen AF, Andersen B, Vedsted P. Identify- ing specific non-attending groups in breast cancer screen- ing - population-based registry study of participation and socio-demography. BMC Cancer 2012;12:518-522.